- Uses pyrenedecanoic acid (PDA) as probe
- readout by flow cytometer and microscopy
- Cited in over 35 publications
- Fluorescent Cell Imaging
Supplier Data
Fluorescent Cell Imaging - Membrane fluidity kit (AB189819)
Membrane Fluidity Kit.
Ethanol treatment increases membrane fluidity in HeLa cells
HeLa cells were treated with 100mM or 200 mM Ethanol for 48 hours, followed by 1 hour incubation with 2 μM PDA and 0.08% pluronic F-127. PDA fluorescence was monitored by exciting at 350 nM and taking emission values at 400nM (monomer) and 470nM (excimer). Relative membrane fluidity is a ratio of excimer to monomer fluorescence. Aliphatic alcohols such as EtOH are known to increase membrane fluidity.
- Fluorescent Cell Imaging
Supplier Data
Fluorescent Cell Imaging - Membrane fluidity kit (AB189819)
Membrane Fluidity Kit.
Isopropanol treatment increases membrane fluidity in primary leukocytes
Primary leukocytes were treated with .5% isopropanol for 1 hour, followed by 1 hour incubation with 5 μM PDA and 0.08% pluronic F-127. PDA fluorescence was measured by exciting at 350 nM and taking emission values at 400nM (monomer) and 460nM (excimer). Relative membrane fluidity is a ratio of excimer to monomer fluorescence.
- Fluorescent Cell Imaging
Supplier Data
Fluorescent Cell Imaging - Membrane fluidity kit (AB189819)
Membrane Fluidity Kit.
Gaucher Disease leukocytes exhibit decreased membrane fluidity relative to healthy controls
Immortalized leukocytes were incubated for 1 hour incubation with 2 μM PDA and 0.08% pluronic F-127. PDA fluorescence was measured by exciting at 350nM and taking emission values at 400nM (monomer) and 470nM (excimer). Relative membrane fluidity is a ratio of excimer to monomer fluorescence. Previous studies have demonstrated that cells isolated from Gaucher Disease patients exhibit decreased membrane fluidity.
Product details
How the assay works
Membrane fluidity or "membrane viscosity" for short range lateral diffusion has best been measured using lipid analog probes that, when interacting, exhibit changes in their spectral properties. One of the best systems for use in such studies are the lipophilic pyrene probes that undergo excimer formation upon spatial interaction. When excimers form, the emission spectrum of the pyrene probe shifts dramatically to the red (longer wavelength). By measuring the ratio of monomer (EM max. 400 nm) to excimer (EM 470 nm) fluorescence, a quantitative monitoring of the membrane fluidity can be attained. These measurements can provide kinetic information, as well as in vivo monitoring of cellular function by both flow cytometry and microscopic analysis.
The dynamic properties of the cell membrane and cytoplasmic microtubules and microfilaments, as well as the dynamic movement of lipids in micelles and vesicles is of importance in such diverse areas as activation of polymorphonuclear leukocytes and chemotaxis, activation of membrane enzyme systems and the specific assembly or mobilization of microtubules and microfilaments, enhancement of the affinity of chemoattractant receptors, as well as being associated with a variety of pathological syndromes related to membrane fluidity.
It has been recognized that the rotational mobility of fluorescent or magnetic resonant probes is different from that observed in lateral diffusion.
Membrane fluidity kit protocol
Kit size: 100 tests in a 50 μL reaction volume.
1. Plate adherent cells or suspension cell
2. Prepare fluorescent labeling solution
3. Incubate cells with Fluorescent Lipid Reagent for 1 hour
4. Wash cells, resuspend cell in media
5. Read fluorescence at 400nm and 450-470nm
The dynamic properties of the cell membrane and cytoplasmic microtubules and microfilaments, as well as the dynamic movement of lipids in micelles and vesicles is of importance in such diverse areas as activation of polymorphonuclear leukocytes and chemotaxis, activation of membrane enzyme systems and the specific assembly or mobilization of microtubules and microfilaments, enhancement of the affinity of chemoattractant receptors, as well as being associated with a variety of pathological syndromes related to membrane fluidity.
It has been recognized that the rotational mobility of fluorescent or magnetic resonant probes is different from that observed in lateral diffusion.
Kit size: 100 tests in a 50 μL reaction volume.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (49)
Recent publications for all applications. Explore the full list and refine your search
Drug design, development and therapy 19:5471-5488 PubMed40589445
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biofilm 9:100289 PubMed40539031
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of animal science and biotechnology 16:67 PubMed40355956
2025
Applications
Unspecified application
Species
Unspecified reactive species
Communications medicine 5:100 PubMed40181097
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS genetics 21:e1011617 PubMed40048486
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 135: PubMed39903530
2025
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 121:e2408186121 PubMed39475635
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:8214 PubMed39294175
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:110703 PubMed39252977
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:15244 PubMed38956407
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com